A carregar...
Cutaneous Toxicities of Molecular Targeted Therapies
Antineoplastic targeted therapies, such as EGFR inhibitors, tyrosine kinase inhibitors and BRAF inhibitors, frequently lead to systemic and cutaneous side effects, significantly affecting patient’s quality of life. Patients with new targeted therapies have an increased risk of developing skin reacti...
Na minha lista:
| Publicado no: | Maedica (Bucur) |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
EDITORIAL POINT OF VIEW
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5574072/ https://ncbi.nlm.nih.gov/pubmed/28878837 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|